Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples